Lenacapavir HIV Prevention Injection to Reach Too Few
...
Subscription Required
You must be a subscriber to access all of this content.
Already a subscriber? Log in here
Perinatal Mental Health: Risks and Solutions in Pregnancy
...
Subscription Required
You must be a subscriber to access all of this content.
Already a subscriber? Log in here
Healthcare Investment Drives Growth and Productivity
Discover how healthcare investment drives growth, linking public health to stronger GDP performance in emerging markets.
Subscription Required
You must be a subscriber to access all of this content.
Already a subscriber? Log in here
Barrs Pharmaceuticals Secures R92m Hetero Investment
...
Subscription Required
You must be a subscriber to access all of this content.
Already a subscriber? Log in here
US WHO Withdrawal Official, Organisation Plans Deep Cuts
The US WHO Withdrawal became final in January 2026, raising risks for flu surveillance, outbreak response, and WHO funding as job cuts loom.
Subscription Required
You must be a subscriber to access all of this content.
Already a subscriber? Log in here
Human HIV Vaccine Trial Begins With BRILLIANT 011
South Africa launches the HIV vaccine trial, BRILLIANT 01, testing a new vaccine cocktail designed to prime broadly neutralising antibodies.
Subscription Required
You must be a subscriber to access all of this content.
Already a subscriber? Log in here